What is the size of the neuropathic pain market in 2026?

The global neuropathic pain market is estimated to be valued at US$ 9.6 billion in 2026.

What are the primary demand drivers in the neuropathic pain market?

Rising diabetes prevalence, aging populations, cancer therapies, chronic pain incidence, and increasing neuropathy diagnosis rates.

Which region leads the neuropathic pain market?

North America is the leading regional market, accounting for approximately 43% of global revenue in 2025.

What are the key opportunities in the neuropathic pain market?

Development of non-opioid therapies, topical treatments, precision medicines, and expanding healthcare access in emerging markets.

Who are the key market players in the neuropathic pain market?

The market is led by Pfizer Inc. (pregabalin/Lyrica franchise), Eli Lilly and Company (duloxetine/Cymbalta), Novartis AG, Abbott (spinal cord stimulation), Teva Pharmaceutical Industries, and Viatris in generics.

Table of Content - Neuropathic Pain Market Size, Share, and Growth Forecast 2026

Executive Summary
1. Global Neuropathic Pain Market Snapshot 2026 and 2033
2. Market Opportunity Assessment, 2026-2033, US$ Bn
3. Key Market Trends
4. Industry Developments and Key Market Events
5. Demand Side and Supply Side Analysis
6. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definitions
2. Market Dynamics
  1. Driver
  2. Restraint
  3. Opportunities
  4. Trends
3. Macro-Economic Factors
  1. Global GDP Outlook
  2. Global Sectorial Outlook
  3. Global GDP Growth Outlook
4. Forecast Factors - Relevance and Impact
5. COVID-19 Impact Assessment
Value Added Insights
1. Value Chain analysis
2. Key Market Players
3. Product Adoption Analysis
4. Key Promotional Strategies by key players
5. PESTLE Analysis
6. Porter's Five Forces Analysis
7. Regulatory and Technology Landscape
Global Neuropathic Pain Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
1. Key Highlights
2. Global Neuropathic Pain Market Outlook: Drug Class
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by Drug Class, 2020-2025
  3. Current Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
    1. Tricyclic Anti-Depressants
    2. Anticonvulsants
    3. SNRI's
    4. Topical Anesthetics
    5. Opioids
    6. Others
  4. Market Attractiveness Analysis: Drug Class
3. Global Neuropathic Pain Market Outlook: Indication
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by Indication, 2020-2025
  3. Current Market Size (US$ Bn) Forecast, by Indication, 2026-2033
    1. Diabetic Neuropathy
    2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
    3. Post-Herpetic Neuralgia (PHN)
    4. Trigeminal Neuralgia
    5. Spinal Cord Injury-Associated Neuropathy
    6. Phantom Limb Pain
    7. Multiple Sclerosis-Associated Neuropathy
    8. Others
  4. Market Attractiveness Analysis: Indication
4. Global Neuropathic Pain Market Outlook: Route of Administration
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by Route of Administration, 2020-2025
  3. Current Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
    1. Oral
    2. Topical
    3. Parenteral
  4. Market Attractiveness Analysis: Route of Administration
5. Global Neuropathic Pain Market Outlook: Distribution Channel
  1. Introduction/Key Findings
  2. Historical Market Size (US$ Bn) Analysis by Distribution Channel, 2020-2025
  3. Current Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  4. Market Attractiveness Analysis: Distribution Channel
Global Neuropathic Pain Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia & Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Neuropathic Pain Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
1. Key Highlights
2. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. U.S.
  2. Canada
3. North America Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
  1. Tricyclic Anti-Depressants
  2. Anticonvulsants
  3. SNRI's
  4. Topical Anesthetics
  5. Opioids
  6. Others
4. North America Market Size (US$ Bn) Forecast, by Indication, 2026-2033
  1. Diabetic Neuropathy
  2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
  3. Post-Herpetic Neuralgia (PHN)
  4. Trigeminal Neuralgia
  5. Spinal Cord Injury-Associated Neuropathy
  6. Phantom Limb Pain
  7. Multiple Sclerosis-Associated Neuropathy
  8. Others
5. North America Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Topical
  3. Parenteral
6. North America Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Europe Neuropathic Pain Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
1. Key Highlights
2. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. Germany
  2. Italy
  3. France
  4. U.K.
  5. Spain
  6. Russia
  7. Rest of Europe
3. Europe Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
  1. Tricyclic Anti-Depressants
  2. Anticonvulsants
  3. SNRI's
  4. Topical Anesthetics
  5. Opioids
  6. Others
4. Europe Market Size (US$ Bn) Forecast, by Indication, 2026-2033
  1. Diabetic Neuropathy
  2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
  3. Post-Herpetic Neuralgia (PHN)
  4. Trigeminal Neuralgia
  5. Spinal Cord Injury-Associated Neuropathy
  6. Phantom Limb Pain
  7. Multiple Sclerosis-Associated Neuropathy
  8. Others
5. Europe Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Topical
  3. Parenteral
6. Europe Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
East Asia Neuropathic Pain Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
1. Key Highlights
2. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. China
  2. Japan
  3. South Korea
3. East Asia Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
  1. Tricyclic Anti-Depressants
  2. Anticonvulsants
  3. SNRI's
  4. Topical Anesthetics
  5. Opioids
  6. Others
4. East Asia Market Size (US$ Bn) Forecast, by Indication, 2026-2033
  1. Diabetic Neuropathy
  2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
  3. Post-Herpetic Neuralgia (PHN)
  4. Trigeminal Neuralgia
  5. Spinal Cord Injury-Associated Neuropathy
  6. Phantom Limb Pain
  7. Multiple Sclerosis-Associated Neuropathy
  8. Others
5. East Asia Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Topical
  3. Parenteral
6. East Asia Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
South Asia & Oceania Neuropathic Pain Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
1. Key Highlights
2. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of SAO
3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
  1. Tricyclic Anti-Depressants
  2. Anticonvulsants
  3. SNRI's
  4. Topical Anesthetics
  5. Opioids
  6. Others
4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Indication, 2026-2033
  1. Diabetic Neuropathy
  2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
  3. Post-Herpetic Neuralgia (PHN)
  4. Trigeminal Neuralgia
  5. Spinal Cord Injury-Associated Neuropathy
  6. Phantom Limb Pain
  7. Multiple Sclerosis-Associated Neuropathy
  8. Others
5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Topical
  3. Parenteral
6. South Asia & Oceania Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Latin America Neuropathic Pain Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
1. Key Highlights
2. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. Brazil
  2. Mexico
  3. Rest of LATAM
3. Latin America Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
  1. Tricyclic Anti-Depressants
  2. Anticonvulsants
  3. SNRI's
  4. Topical Anesthetics
  5. Opioids
  6. Others
4. Latin America Market Size (US$ Bn) Forecast, by Indication, 2026-2033
  1. Diabetic Neuropathy
  2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
  3. Post-Herpetic Neuralgia (PHN)
  4. Trigeminal Neuralgia
  5. Spinal Cord Injury-Associated Neuropathy
  6. Phantom Limb Pain
  7. Multiple Sclerosis-Associated Neuropathy
  8. Others
5. Latin America Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Topical
  3. Parenteral
6. Latin America Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Middle East & Africa Neuropathic Pain Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
1. Key Highlights
2. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
  1. GCC Countries
  2. South Africa
  3. Northern Africa
  4. Rest of MEA
3. Middle East & Africa Market Size (US$ Bn) Forecast, by Drug Class, 2026-2033
  1. Tricyclic Anti-Depressants
  2. Anticonvulsants
  3. SNRI's
  4. Topical Anesthetics
  5. Opioids
  6. Others
4. Middle East & Africa Market Size (US$ Bn) Forecast, by Indication, 2026-2033
  1. Diabetic Neuropathy
  2. Chemotherapy-Induced Peripheral Neuropathy (CIPN)
  3. Post-Herpetic Neuralgia (PHN)
  4. Trigeminal Neuralgia
  5. Spinal Cord Injury-Associated Neuropathy
  6. Phantom Limb Pain
  7. Multiple Sclerosis-Associated Neuropathy
  8. Others
5. Middle East & Africa Market Size (US$ Bn) Forecast, by Route of Administration, 2026-2033
  1. Oral
  2. Topical
  3. Parenteral
6. Middle East & Africa Market Size (US$ Bn) Forecast, by Distribution Channel, 2026-2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping
  2. Competition Dashboard
3. Company Profiles
  1. Almatica
    1. Company Overview
    2. Product Portfolio/Offerings
    3. Key Financials
    4. SWOT Analysis
    5. Company Strategy and Key Developments
  2. Vertex Pharmaceuticals Incorporated
  3. Azurity Pharmaceuticals, Inc.
  4. Pfizer Inc.
  5. Viatris Inc.
  6. Supernus Pharmaceuticals, Inc.
  7. Novartis AG
  8. Accord Healthcare
  9. Focus Health Group
  10. Amneal Pharmaceuticals LLC
  11. Abbott
  12. Teva Pharmaceutical Industries Ltd.
  13. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Neuropathic Pain Market Size, Share, and Growth Forecast 2026 - 2033

Quick Links

Our Partners

Secure Payments Through